PortfoliosLab logoPortfoliosLab logo
THNR vs. BITY
Performance
Return for Risk
Drawdowns
Volatility
Dividends

Performance

THNR vs. BITY - Performance Comparison

The chart below illustrates the hypothetical performance of a $10,000 investment in Amplify Weight Loss Drug & Treatment ETF (THNR) and Amplify Bitcoin 2% Monthly Option Income ETF (BITY). The values are adjusted to include any dividend payments, if applicable.

Loading charts...

Returns By Period

In the year-to-date period, THNR achieves a -5.20% return, which is significantly higher than BITY's -21.03% return.


THNR

1D
-1.47%
1M
-2.91%
YTD
-5.20%
6M
-3.73%
1Y
9.10%
3Y*
5Y*
10Y*

BITY

1D
-6.46%
1M
-16.08%
YTD
-21.03%
6M
-23.28%
1Y
-34.72%
3Y*
5Y*
10Y*
*Multi-year figures are annualized to reflect compound growth (CAGR)

THNR vs. BITY - Yearly Performance Comparison


Correlation

The correlation between THNR and BITY is 0.30, which is low. Their price movements are largely independent, making them effective diversification partners.


Correlation
Correlation (1Y)
Calculated over the trailing 1-year period

0.30

Correlation (All Time)
Calculated using the full available price history since Apr 30, 2025

0.26

Compare stocks, funds, or ETFs

Search for stocks, ETFs, and funds for a quick comparison or use the comparison tool for more options.


Return for Risk

THNR vs. BITY — Risk / Return Rank

Compare risk-adjusted metric ranks to identify better-performing investments over the past 12 months.

THNR
THNR Risk / Return Rank: 1616
Overall Rank
THNR Sharpe Ratio Rank: 1515
Sharpe Ratio Rank
THNR Sortino Ratio Rank: 1616
Sortino Ratio Rank
THNR Omega Ratio Rank: 1515
Omega Ratio Rank
THNR Calmar Ratio Rank: 1818
Calmar Ratio Rank
THNR Martin Ratio Rank: 1717
Martin Ratio Rank

BITY
BITY Risk / Return Rank: 22
Overall Rank
BITY Sharpe Ratio Rank: 22
Sharpe Ratio Rank
BITY Sortino Ratio Rank: 22
Sortino Ratio Rank
BITY Omega Ratio Rank: 22
Omega Ratio Rank
BITY Calmar Ratio Rank: 22
Calmar Ratio Rank
BITY Martin Ratio Rank: 22
Martin Ratio Rank
The rank (0–100) shows how this investment's returns compare to the risk taken. Higher = better. Based on the past 12 months of data, combining Sharpe, Sortino, and other metrics used by quantitative funds and institutional investors.

THNR vs. BITY - Risk-Adjusted Trends Comparison

This table presents a comparison of risk-adjusted performance metrics for Amplify Weight Loss Drug & Treatment ETF (THNR) and Amplify Bitcoin 2% Monthly Option Income ETF (BITY). Risk-adjusted metrics are performance indicators that assess an investment's returns in relation to its risk, enabling a more accurate comparison of different investment options.


THNRBITYDifference

Sharpe ratio

Return per unit of total volatility

0.48

-0.87

+1.35

Sortino ratio

Return per unit of downside risk

0.81

-1.17

+1.98

Omega ratio

Gain probability vs. loss probability

1.10

0.87

+0.23

Calmar ratio

Return relative to maximum drawdown

0.76

-0.75

+1.51

Martin ratio

Return relative to average drawdown

1.75

-1.32

+3.07

THNR vs. BITY - Sharpe Ratio Comparison

The current THNR Sharpe Ratio is 0.48, which is higher than the BITY Sharpe Ratio of -0.87. The chart below compares the historical Sharpe Ratios of THNR and BITY, calculated using daily returns over the previous 12 months. A higher Sharpe Ratio indicates better risk-adjusted performance relative to the risk-free rate.


Loading charts...

Sharpe Ratios by Period


THNRBITYDifference

Sharpe Ratio (1Y)

Calculated over the trailing 1-year period

0.48

-0.87

+1.35

Sharpe Ratio (All Time)

Calculated using the full available price history

-0.09

-0.66

+0.57

Drawdowns

THNR vs. BITY - Drawdown Comparison

The maximum THNR drawdown since its inception was -32.51%, smaller than the maximum BITY drawdown of -46.36%. Use the drawdown chart below to compare losses from any high point for THNR and BITY.


Loading charts...

Drawdown Indicators


THNRBITYDifference

Max Drawdown

Largest peak-to-trough decline

-32.51%

-46.36%

+13.85%

Max Drawdown (1Y)

Largest decline over 1 year

-12.06%

-46.36%

+34.30%

Current Drawdown

Current decline from peak

-13.00%

-44.03%

+31.03%

Average Drawdown

Average peak-to-trough decline

-12.24%

-19.58%

+7.34%

Ulcer Index

Depth and duration of drawdowns from previous peaks

5.26%

26.33%

-21.07%

Volatility

THNR vs. BITY - Volatility Comparison

The current volatility for Amplify Weight Loss Drug & Treatment ETF (THNR) is 5.16%, while Amplify Bitcoin 2% Monthly Option Income ETF (BITY) has a volatility of 9.89%. This indicates that THNR experiences smaller price fluctuations and is considered to be less risky than BITY based on this measure. The chart below showcases a comparison of their rolling one-month volatility.


Loading charts...

Volatility by Period


THNRBITYDifference

Volatility (1M)

Calculated over the trailing 1-month period

5.16%

9.89%

-4.73%

Volatility (6M)

Calculated over the trailing 6-month period

13.55%

31.50%

-17.95%

Volatility (1Y)

Calculated over the trailing 1-year period

19.15%

39.86%

-20.71%

Volatility (5Y)

Calculated over the trailing 5-year period, annualized

19.37%

39.02%

-19.65%

Volatility (10Y)

Calculated over the trailing 10-year period, annualized

19.37%

39.02%

-19.65%

THNR vs. BITY - Expense Ratio Comparison

THNR has a 0.59% expense ratio, which is lower than BITY's 0.65% expense ratio.


Dividends

THNR vs. BITY - Dividend Comparison

THNR's dividend yield for the trailing twelve months is around 1.73%, less than BITY's 38.62% yield.


PositionTTM20252024
BITY
Amplify Bitcoin 2% Monthly Option Income ETF
38.62%21.53%0.00%
THNR
Amplify Weight Loss Drug & Treatment ETF
1.73%1.64%0.98%

Frequently Asked Questions


THNR and BITY have a correlation of 0.30, meaning they provide meaningful diversification benefit when combined. Depending on your allocation goals, holding both could reduce overall portfolio risk.

BITY has higher volatility (9.89%) compared to THNR (5.16%). In terms of maximum drawdown, THNR dropped -32.51% vs BITY's -46.36%.

On 1-year performance, THNR leads with 9.10% vs -34.72% for BITY. On fees, THNR is cheaper at 0.59% per year. On volatility, THNR has been the lower-risk option at 5.16%. The better choice depends on whether you care most about return, fees, risk, or income.

Over the 1-year period, THNR has performed better with a 9.10% return vs -34.72%. Past performance does not guarantee future results, so compare this with risk, fees, and fund exposure.

THNR is cheaper with a 0.59% expense ratio, compared with 0.65% for BITY.

BITY has the higher dividend yield at 38.62%, compared with 1.73% for THNR.

THNR is categorized as Health & Biotech Equities, while BITY is Derivative Income. Their fees differ too: 0.59% for THNR and 0.65% for BITY.

THNR currently has the higher Sharpe Ratio (0.48 vs -0.87), meaning it's delivered slightly more return per unit of risk over the trailing 12 months. However, this ranking shifts over time - use the Risk/Return Score above for a more comprehensive view that combines Sharpe, Sortino, and other measures used by quantitative funds.

Portfolio Optimizer

Find the right allocation for THNR and BITY

Add both to a portfolio and optimize allocations for your target — whether that's maximizing returns, minimizing drawdowns, or balancing risk across holdings.

Open Portfolio Optimizer